The numbers of patients who experienced permanent drug discontinuation because of neutropenia, ALT increased, AST increased, and QTcF prolongation were 18 (0.6%), 197 (6.1%), 129 (4.0%), and 8 (0.2%), respectively. Here, GPT is linked to neutropenia.